Literature DB >> 2153437

Natural killer cell activity in patients with hepatocellular carcinoma relative to early development and tumor invasion.

W L Chuang1, H W Liu, W Y Chang.   

Abstract

To evaluate the significance of natural killer (NK) cell activity in the clinical assessment of patients with hepatocellular carcinoma (HCC), 32 patients combined with liver cirrhosis (LC) and HCC, and 29 LC patients were studied. The NK cell activity was markedly decreased in HCC patients and the LC group as compared with the control group, but there was no statistical difference between the NK cell activity of the HCC group and the LC group. The depression of NK cell activity in HCC patients was inversely correlated with the patient's age, and the HCC patients with venous invasion or with both lobes involved had lower NK cell activity. These results suggest that the decreased NK cell activity in HCC patients might be related to the coexistent liver disease, and marked decrease in NK cell activity might be one of the causes for the early development and invasion of HCC.

Entities:  

Mesh:

Year:  1990        PMID: 2153437     DOI: 10.1002/1097-0142(19900215)65:4<926::aid-cncr2820650418>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

Review 1.  Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies.

Authors:  Sayed Shahabuddin Hoseini; Nai-Kong V Cheung
Journal:  Cancer Lett       Date:  2017-04-17       Impact factor: 8.679

2.  Ex vivo generation of highly purified and activated natural killer cells from human peripheral blood.

Authors:  Satoru Saito; Yui Harada; Yosuke Morodomi; Mitsuho Onimaru; Kumi Yoshida; Ryoichi Kyuragi; Hisahiro Matsubara; Yoshikazu Yonemitsu
Journal:  Hum Gene Ther Methods       Date:  2013-08       Impact factor: 2.396

3.  Immunosuppressive effect of chenodeoxycholic acid on natural killer cell activity in patients with biliary atresia and hepatitis C virus-related liver cirrhosis.

Authors:  Masaru Hirata; Yasushi Harihara; Yoshiaki Kita; Shoichi Saito; Motoko Nishimuraj; Hiroyuki Yoshino; Keiji Sano; Mitsuhiro Ito; Koji Kusaka; Hideo Kawarasaki; Kohei Hashizume; Masatoshi Makuuchi
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

Review 4.  Immunobiology of hepatocellular carcinoma.

Authors:  Tobias Flecken; Hans Christian Spangenberg; Robert Thimme
Journal:  Langenbecks Arch Surg       Date:  2011-04-09       Impact factor: 3.445

5.  Reduction of virus burden-induced splenectomy in patients with liver cirrhosis related to hepatitis C virus infection.

Authors:  Tetsuro Sekiguchi; Takeaki Nagamine; Hitoshi Takagi; Masatomo Mori
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

Review 6.  Immunobiology of hepatocarcinogenesis: Ways to go or almost there?

Authors:  Pavan Patel; Steven E Schutzer; Nikolaos Pyrsopoulos
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

Review 7.  HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.

Authors:  M Campoli; S Ferrone
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

8.  Hepatocellular carcinoma with extrahepatic primary neoplasms.

Authors:  M Kanematsu; T Imaeda; Y Yamawaki; Y Hirose; A Inoue; H Goto; H Doi
Journal:  Gastrointest Radiol       Date:  1992

Review 9.  Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.

Authors:  Bin Gao; Svetlana Radaeva; Ogyi Park
Journal:  J Leukoc Biol       Date:  2009-09       Impact factor: 4.962

Review 10.  NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma.

Authors:  Cheng Sun; Haoyu Sun; Cai Zhang; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2014-10-13       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.